The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Scope of the Report:
North America is the largest consumption market of Marine Pharmaceuticals, with sales market share nearly 33.4% in 2018. The second place is Europe; following North America with the sales market share over 23.3%, China and Japan are also an important sales area. In 2018, The global marine pharmaceuticals market will observe steady growth because of the robust growth in APAC during the forecast period. But, the market shares of the Americas and EMEA will decline to some extent during the forecast period. APAC will be a leader in market growth during the forecast period owing to the increasing awareness and improved access to healthcare.
The worldwide market for Marine Pharmaceuticals is expected to grow at a CAGR of roughly 8.1% over the next five years, will reach 34080 million US$ in 2024, from 23050 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Marine Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Drugs
Health Supplement
Market Segment by Applications, can be divided into
Hospital & Clinic
Pharmacy
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Marine Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Marine Pharmaceuticals, with price, sales, revenue and global market share of Marine Pharmaceuticals in 2017 and 2018.
Chapter 3, the Marine Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Marine Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Marine Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Marine Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Summary:
Get latest Market Research Reports on Marine Pharmaceuticals . Industry analysis & Market Report on Marine Pharmaceuticals is a syndicated market report, published as Global Marine Pharmaceuticals Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Marine Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.